Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05547048 · ClinicalTrials.gov registry record · Phase 4
Integrated e-Health (Electronic Health) for HIV and Substance Use Disorders in Justice Involved Women
A Phase 4 study of HIV and Opioid Use Disorder, sponsored by Yale University.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 250
- Enrollment target
- 2
- Study locations
NCT05547048 is a Phase 4 study of HIV and Opioid Use Disorder that is actively recruiting participants, run by Yale University. The registered enrollment target is 250 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (43% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT05547048, a Phase 4 study of HIV and Opioid Use Disorder, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 250 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this 2-site (CT, AL) study is to test innovative interventions to reduce stigma and improve the pre-exposure prophylaxis (PrEP) and opioid use disorder (OUD) care continua in women involved in the criminal justice system (WICJ). This study evaluates a newly validated PrEP decision aid and eHealth for integrated PrEP and MOUD compared to a decision aid-only for WICJ with OUD.
Conditions Studied
Interventions
- BEHAVIORAL Decision Aid
- COMBINATION_PRODUCT Athena strategy
Study Locations (2)
Alabama
- University of Alabama in Birmingham - Birmingham
Connecticut
- Yale University - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2023-07-25 |
| Est. Completion | 2027-04-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05547048
The ClinicalTrials.gov registry entry for NCT05547048 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 439-participant average among 303 other HIV trials with a reported enrollment target (43% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with HIV appearing as the primary indexed condition, and to 2 interventions - of which Decision Aid is the first listed.
NCT05547048 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Alabama, Connecticut.
Frequently Asked Questions
What is clinical trial NCT05547048 about?
NCT05547048 is a clinical study titled "Integrated e-Health (Electronic Health) for HIV and Substance Use Disorders in Justice Involved Women". The purpose of this 2-site (CT, AL) study is to test innovative interventions to reduce stigma and improve the pre-exposure prophylaxis (PrEP) and opioid use disorder (OUD) care continua in women involved in the criminal justice system (WICJ). This study evaluates a newly validated PrEP decision ai...
What is the current status of trial NCT05547048?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 250 participants. The study started on 2023-07-25. Estimated completion is 2027-04-01.
What conditions does trial NCT05547048 study?
This clinical trial studies the following conditions: HIV, Opioid Use Disorder, eHealth.
What interventions are being tested in trial NCT05547048?
The interventions under investigation include: Decision Aid (BEHAVIORAL), Athena strategy (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT05547048?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05547048 being conducted?
This trial has 2 study locations across Alabama, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Assessment of Metformin for Restoration of Immune Homeostasis in HIV+ and HIV- Individuals With a History of Injection Drug Use
RECRUITING · Phase 4
-
Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject Drugs
RECRUITING · Phase 4
-
Implementation and Deliver of Lenacapavir for PrEP in a Community Pharmacy Setting
RECRUITING · Phase 4
-
Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP
RECRUITING · Phase 4
-
Immediate Initiation of Antiretroviral Therapy During "Hyperacute" HIV Infection
ACTIVE NOT RECRUITING · Phase 4
-
Emtricitabine/Tenofovir Alafenamide Switch Study for Transgender Individuals for HIV Pre-exposure Prophylaxis
ACTIVE NOT RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.